Fate Therapeutics Inc (FATE): (OT): Augmenting CAR NK cell Anti-tumor...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	33
Posts	2861
Boards Moderated	1
Alias Born	10/24/2015

jondoeuk

Re: None

Tuesday, 11/01/2022 5:53:34 PM

Tuesday, November 01, 2022 5:53:34 PM

(OT): Augmenting CAR NK cell Anti-tumor Activity by Synapse Tuning https://www.biorxiv.org/content/10.1101/2022.10.26.512898v1.full

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent FATE News

Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/12/2024 08:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:21:54 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:26:21 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:08:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:06:21 PM
Fate Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 08/13/2024 08:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:01:01 PM
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/02/2024 08:01:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 10:05:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 10:01:44 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 10:00:56 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 09:59:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:03:29 PM
Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/02/2024 08:01:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 10:20:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:30:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:28:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:28:42 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/10/2024 09:05:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:26:59 PM
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/04/2024 08:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 09:24:29 PM
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 08:01:00 PM

More FATE News

InvestorsHub NewsWire

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover